These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 7129438)
21. The use of flanking markers in prediction for Duchenne muscular dystrophy. Williams H; Sarfarazi M; Brown C; Thomas N; Harper PS Arch Dis Child; 1986 Mar; 61(3):218-22. PubMed ID: 3457554 [TBL] [Abstract][Full Text] [Related]
22. Racial effect on serum creatine-kinase: implications for estimation of heterozygosity risks for females at-risk for Duchenne dystrophy. Passos-Bueno MR; Rabbi-Bortolini E; Azevêdo E; Zatz M Clin Chim Acta; 1989 Feb; 179(2):163-8. PubMed ID: 2920447 [No Abstract] [Full Text] [Related]
23. Carrier detection in Duchenne muscular dystrophy. Carter CO Lancet; 1979 May; 1(8123):979. PubMed ID: 87648 [No Abstract] [Full Text] [Related]
35. Duchenne muscular dystrophy. Use of rubidium chloride Rb 86 in the detection of carriers of the gene. Bradley WG; Gardner-Medwin D; Haggith J; Walton JN; Hesp R Arch Neurol; 1971 Sep; 25(3):193-7. PubMed ID: 4951942 [No Abstract] [Full Text] [Related]
36. 50 Years Ago in The Journal of Pediatrics: An Assessment of the Creatine Kinase Test in the Detection of Carriers of Duchenne Muscular Dystrophy. Cardon MW J Pediatr; 2017 Jul; 186():63. PubMed ID: 28648283 [No Abstract] [Full Text] [Related]
37. Gallium-67 citrate localization in carriers of Duchenne muscular dystrophy. Brown RG; Ash JM; Verellen-Dumoulin C; Percy ME; Chang LS; Oss I; Fulford P Int J Nucl Med Biol; 1981; 8(4):379-88. PubMed ID: 6948790 [No Abstract] [Full Text] [Related]